Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Shiba Inu 2025 Forecast: $0.00005 Anticipated With Ozak AI Reaching $1 on AI Hype July 15, 2025 XRP ETF News: 3iQ’s XRPQ Crosses $50M AUM in Just 23 Days July 15, 2025 Ethereum, Solana, Remittix and Pi Network Price Predictions For 15th-31st July July 15, 2025